Outpatient treatment in low-risk pulmonary embolism patients receiving direct acting oral anticoagulants is associated with cost savings

R Ghazvinian, J Elf, S Löfvendahl… - Clinical and Applied …, 2020 - journals.sagepub.com
Direct oral anticoagulants (DOAC) are first line treatment for pulmonary embolism (PE).
Treatment of acute PE is traditionally hospital based and associated with high costs. The …

Outpatient treatment in low-risk pulmonary embolism patients receiving direct acting oral anticoagulants is associated with cost savings.

R Ghazvinian, J Elf, A Gottsäter, S Löfvendahl, J Holst - 2020 - researchsquare.com
Background Direct oral anticoagulants (DOAC) are first line treatment for pulmonary
embolism (PE). Treatment of acute PE is traditionally hospital based and associated with …

Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings

R Ghazvinian, J Elf, S Löfvendahl, J Holst… - Clinical and Applied …, 2020 - lup.lub.lu.se
Direct oral anticoagulants (DOAC) are first line treatment for pulmonary embolism (PE).
Treatment of acute PE is traditionally hospital based and associated with high costs. The …

Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings.

R Ghazvinian, J Elf, S Löfvendahl… - Clinical & Applied …, 2020 - search.ebscohost.com
Direct oral anticoagulants (DOAC) are first line treatment for pulmonary embolism (PE).
Treatment of acute PE is traditionally hospital based and associated with high costs. The …

Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings

R Ghazvinian, J Elf, S Löfvendahl… - … : official journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Direct oral anticoagulants (DOAC) are first line treatment for pulmonary embolism (PE).
Treatment of acute PE is traditionally hospital based and associated with high costs. The …

Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings

R Ghazvinian, J Elf, S Löfvendahl… - Clinical and Applied …, 2020 - portal.research.lu.se
Direct oral anticoagulants (DOAC) are first line treatment for pulmonary embolism (PE).
Treatment of acute PE is traditionally hospital based and associated with high costs. The …

Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings.

R Ghazvinian, J Elf, S Löfvendahl, J Holst… - Clinical and Applied …, 2020 - europepmc.org
Direct oral anticoagulants (DOAC) are first line treatment for pulmonary embolism (PE).
Treatment of acute PE is traditionally hospital based and associated with high costs. The …

[HTML][HTML] Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings

R Ghazvinian, J Elf, S Löfvendahl, J Holst… - Clinical and Applied …, 2020 - ncbi.nlm.nih.gov
Direct oral anticoagulants (DOAC) are first line treatment for pulmonary embolism (PE).
Treatment of acute PE is traditionally hospital based and associated with high costs. The …

Outpatient treatment in low-risk pulmonary embolism patients receiving direct acting oral anticoagulants is associated with cost savings.

R Ghazvinian, J Elf, A Gottsäter, S Löfvendahl, J Holst - 2020 - europepmc.org
Background: Direct oral anticoagulants (DOAC) are first line treatment for pulmonary
embolism (PE). Treatment of acute PE is traditionally hospital based and associated with …

[引用][C] Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings

R Ghazvinian, J Elf, S Löfvendahl, J Holst, A Gottsäter - portal.research.lu.se
Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting
Oral Anticoagulants Is Associated With Cost Savings – Research output — Lund University …